New Mexico Clinical Trials Report — May 2026

For New Mexicans considering participation in clinical research, May 2026 brings an important reminder to act swiftly, particularly for those interested in trials nearing their enrollment deadlines. Across the state, 24 clinical trials are scheduled to close within the next 90 days. This includes opportunities for healthy volunteers, with 5 of these studies still actively seeking participants without specific health conditions. Individuals interested in contributing to medical advancements should explore these options promptly before they are no longer available.

Patients managing certain health conditions also have a limited window to join research. Trials focused on a variety of conditions are closing soon, offering a final chance for enrollment. Conditions with trials nearing their end include:

• Autism spectrum disorder
• Advance care planning
• Avascular necrosis
• Advanced breast cancer
• Autism or autistic traits
• Chronic kidney disease, receiving dialysis
• Advance directives
• Breast cancer
• Cancer
• Cervical carcinoma

A New Opportunity in Las Cruces

This month, New Mexico saw the opening of 1 new clinical trial, located in Las Cruces. This new study, sponsored by the Fred Hutchinson Cancer Center, is focused on tobacco-related carcinoma. It represents a specific opportunity for individuals in the Las Cruces area who may be impacted by this condition or are interested in contributing to research in this critical area.

Notably, this new trial is also accepting healthy volunteers, offering a chance for individuals without a specific diagnosis to contribute to medical understanding. This adds to the existing opportunities for healthy volunteers across the state, which currently number 34 trials.

While the opening of a single new trial this month is a decrease compared to previous periods—for instance, March 2026 also saw 1 new trial, but earlier months like December 2025 had 18 new trials—the state continues to host a diverse array of ongoing research. The overall landscape includes 382 clinical trials currently recruiting across 13 cities and 198 research sites throughout New Mexico.

New Mexico's Broad Research Landscape

Clinical research in New Mexico extends beyond the major metropolitan areas, with trials recruiting in a variety of cities. The single new trial this month opened in Las Cruces, highlighting the spread of research opportunities. While the data does not specify the distribution of all 382 ongoing trials, the presence of 13 cities hosting research sites indicates a statewide commitment to making clinical trials accessible to a wider population.

For those looking to participate, the eligibility criteria for the new trial this month do not specify restrictions based on age or gender. There are no new trials exclusively for children, female-only, male-only, or older adults this month. This means the new opportunity is broadly accessible to adult participants who meet the specific criteria for tobacco-related carcinoma research or healthy volunteer status.

The research community in New Mexico, supported by institutions like the Fred Hutchinson Cancer Center, continues to advance medical knowledge. The ongoing trials cover a wide range of conditions and therapeutic areas, providing numerous avenues for individuals to get involved in studies that could lead to new treatments and improved care.

As we look ahead, the continued activity in clinical research across New Mexico offers promising avenues for both patients and healthy individuals to contribute to scientific progress, with new opportunities emerging alongside ongoing studies.